HIC IDN 2026 | Panel discussion 3: Addressing the Diabetes Challenge Through Integrated Approaches

HIC IDN 2026 is pleased to present Panel Discussion 3 : Addressing the Diabetes Challenge Through Integrated Approaches. Moderated by Ir. Dr. Nor Ilia Anisa binti Aris of Leave a Nest Malaysia, the session brings together health technologists, clinical researchers and regional health leaders to examine integrated, data driven strategies for diabetes prevention, management and care.

Session overview
Addressing the diabetes challenge requires more than single technologies or one-off programs. This forum explores how digital tools, clinical research and public-sector planning can work together to improve early detection, support long-term behaviour change and deliver scalable care. It will also consider how dietary strategies and thoughtfully selected alternative foods can complement medical and digital interventions to help reduce diabetes risk and support healthier lifestyles. Topics include AI-assisted screening, remote monitoring, clinical-pharmacy approaches and models for university–industry–government collaboration that move promising interventions from pilots into routine care.

Panelists & profile snapshots

Second Heart is a healthtech startup working on diabetes care technologies, including solutions for diabetic foot screening and continuous health management. Mr. Yusuke Mori, Second Heart’s CTO, has industry experience on deploying digital tools that support early detection and sustained patient engagement.

Prof. Keri Lestari is a Professor of Pharmacology and Clinical Pharmacy at Universitas Padjadjaran, founder of lestarikd.innovation and Head of the West Java Research Center at Universitas Padjadjaran. She leads academic governance on research and cooperation, serves as an Independent Commissioner at PT Prodia Widyahusada Tbk and is Vice Chairperson of the Indonesian Pharmacists Association for Advanced and Specialist Pharmacists. Her research and leadership bridge clinical practice, public health and translational programs for chronic-disease management.

Why this matters
Diabetes is a systemic challenge that benefits from integrated approaches: validated screening tech, clinical-pharmacy insights, behaviour-change interventions and aligned public health planning. This panel will surface evidence and partnership models that accelerate proven interventions into larger trials and routine practice, with an eye to accessibility, validation and sustainable impact for communities across the region.

Registration & further information
Details on panel timing, full speaker lineup and registration are available on the HIC IDN 2026 program page <https://hic.lne.st/en/schedule/idn2026-2/>.

For poster registration: https://gqr.sh/66Sz
For attendees registration: https://gqr.sh/66Sz